Loading…Loading…
As the premier gathering of top entrepreneurs and investors took place on Monday in New Jersey, we thought it would be a good time to scroll through the latest leadership changes in the cannabis and psychedelics industries.
Cybin Inc. CYBN (Cboe CA: CYBN) a clinical-stage biopharmaceutical company that develops new and innovative next-generation psychedelic-based treatment options, announced recently that Dr. Atul R. Mahableshwarkar M.D., DLFAPA, opted to join the company as senior vice president of clinical development.
Dr. Mahableshwarkar agreed to lead the development of the CYB003 program, Cybin’s proprietary deuterated psilocybin analog which has received U.S. Food and Drug Administration (FDA) Breakthrough Therapy Designation for the adjunctive treatment of major depressive disorder.
Board Updates At Six Cannabis Companies
The annual general meeting of shareholders of Curaleaf Holdings, Inc. CURA CURLF was held on Friday, during which the following experts were elected as directors:
Boris Jordan; Joseph Lusardi; Dr. Jaswinder Grover; Karl Johansson; Peter Derby; Mitchell Kahn; Shasheen Shah; and Michelle Bodner.
Cannabis powerhouse Planet 13 Holdings Inc. PLTH PLNH named David Loop, the former CEO of VidaCann LLC who has spent his entire career in the horticulture industry, to its board of directors, last week. The Las Vegas company acquired VidaCann May for
